Commerce Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32M Sell
82,632
-8,825
-10% -$3.27M 0.14% 139
2026
Q1
$26.8M Buy
91,457
+34,748
+61% +$11.4M 0.13% 137
2025
Q4
$19.9M Sell
56,709
-36,817
-39% -$12.4M 0.11% 147
2025
Q3
$30.2M Sell
93,526
-94,306
-50% -$29.3M 0.17% 127
2025
Q2
$73.1M Buy
187,832
+4,871
+3% +$1.96M 0.43% 56
2025
Q1
$79.6M Sell
182,961
-6,877
-4% -$2.76M 0.51% 45
2024
Q4
$70M Sell
189,838
-15,952
-8% -$6.68M 0.43% 53
2024
Q3
$107M Buy
205,790
+27,165
+15% +$14.5M 0.66% 35
2024
Q2
$96.8M Buy
178,625
+1,261
+0.7% +$667K 0.63% 38
2024
Q1
$92M Buy
177,364
+654
+0.4% +$325K 0.61% 39
2023
Q4
$83.3M Sell
176,710
-1,936
-1% -$895K 0.59% 38
2023
Q3
$77.8M Sell
178,646
-9,305
-5% -$4.22M 0.61% 40
2023
Q2
$83.5M Sell
187,951
-17,204
-8% -$7.94M 0.62% 36
2023
Q1
$94.3M Sell
205,155
-2,106
-1% -$1M 0.74% 32
2022
Q4
$106M Sell
207,261
-382
-0.2% -$194K 0.86% 24
2022
Q3
$94.3M Sell
207,643
-1,829
-0.9% -$875K 0.82% 24
2022
Q2
$101M Buy
209,472
+2,072
+1% +$1.03M 0.82% 24
2022
Q1
$102M Buy
207,400
+4,475
+2% +$2.05M 0.7% 32
2021
Q4
$94.1M Buy
202,925
+1,686
+0.8% +$709K 0.62% 36
2021
Q3
$75M Buy
201,239
+4,390
+2% +$1.67M 0.53% 46
2021
Q2
$75.2M Buy
196,849
+2,716
+1% +$1.04M 0.53% 50
2021
Q1
$69.7M Buy
194,133
+4,162
+2% +$1.34M 0.53% 50
2020
Q4
$61M Buy
189,971
+59,349
+45% +$18.2M 0.49% 52
2020
Q3
$35.1M Sell
130,622
-7,767
-6% -$2.09M 0.32% 76
2020
Q2
$36.4M Buy
138,389
+3,974
+3% +$1.06M 0.35% 66
2020
Q1
$30.5M Buy
134,415
+19,210
+17% +$5.24M 0.37% 69
2019
Q4
$34.8M Sell
115,205
-3,338
-3% -$919K 0.33% 81
2019
Q3
$28.5M Buy
118,543
+1,316
+1% +$361K 0.29% 88
2019
Q2
$33.1M Sell
117,227
-5,299
-4% -$1.45M 0.37% 71
2019
Q1
$35.2M Buy
122,526
+9,943
+9% +$2.88M 0.42% 66
2018
Q4
$29.6M Buy
112,583
+27,853
+33% +$7.66M 0.38% 72
2018
Q3
$23.2M Buy
84,730
+77,677
+1,101% +$20.2M 0.28% 91
2018
Q2
$1.68M Sell
7,053
-186
-3% -$43.1K 0.02% 325
2018
Q1
$1.59M Sell
7,239
-1,206
-14% -$283K 0.02% 331
2017
Q4
$1.9M Sell
8,445
-3,885
-32% -$827K 0.02% 304
2017
Q3
$2.34M Buy
12,330
+242
+2% +$46.1K 0.03% 266
2017
Q2
$2.27M Buy
12,088
+4,778
+65% +$859K 0.03% 260
2017
Q1
$1.21M Buy
7,310
+599
+9% +$95.3K 0.02% 365
2016
Q4
$964K Sell
6,711
-162
-2% -$21.7K 0.01% 384
2016
Q3
$862K Sell
6,873
-1,627
-19% -$210K 0.01% 403
2016
Q2
$1.12M Buy
8,500
+52
+0.6% +$7.12K 0.02% 361
2016
Q1
$1.17M Sell
8,448
-3,578
-30% -$478K 0.02% 350
2015
Q4
$1.68M Sell
12,026
-1,028
-8% -$142K 0.03% 295
2015
Q3
$1.83M Buy
13,054
+10
+0.1% +$1.5K 0.03% 283
2015
Q2
$2.14M Sell
13,044
-120
-0.9% -$19.2K 0.03% 274
2015
Q1
$2.03M Sell
13,164
-337
-2% -$48K 0.03% 288
2014
Q4
$1.7M Sell
13,501
-150
-1% -$18.5K 0.03% 310
2014
Q3
$1.63M Buy
13,651
+3,324
+32% +$381K 0.03% 307
2014
Q2
$1.11M Sell
10,327
-656
-6% -$67.6K 0.02% 373
2014
Q1
$1.09M Buy
10,983
+505
+5% +$45.7K 0.02% 365
2013
Q4
$968K Sell
10,478
-1,750
-14% -$155K 0.02% 383
2013
Q3
$1.02M Hold
12,228
0.02% 359
2013
Q2
$1M Buy
+12,228
New +$915K 0.02% 356

Other funds holding ELV

Commerce Bank's ELV Position: Q2 2026 in Review

Commerce Bank reduced its Elevance Health (ELV) stake by 9.6% in Q2 2026, selling an estimated $3.27M and leaving 82,632 shares worth $32M. The position accounts for 0.14% of the portfolio, ranked #139.

Commerce Bank first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $107M in Q3 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Commerce Bank held 82,632 shares of Elevance Health worth $32M as of Q2 2026.
  • Commerce Bank sold 8,825 Elevance Health shares in Q2 2026, an estimated $3.27M.
  • Elevance Health made up 0.14% of Commerce Bank's portfolio in Q2 2026, its #139 holding.
  • Commerce Bank first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Commerce Bank's Elevance Health position peaked at $107M in Q3 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.